Redeye leaves a comment following OncoZenge’s announcement of a SEK5m bridge financing via a convertible note with Linc and the formal payment commitment from Yangtian for the delayed third tranche. We are encouraged to see that the company has acted swiftly and decisively to stabilize its short-term financial position, effectively removing the acute liquidity risk and safeguarding continued execution of its strategic and regulatory plans.
LÄS MER
